Case report: complete remission with crizotinib in ROS1 fusion-positive sinonasal mucosal melanoma

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 23,849 followers.

Case report: complete remission with #crizotinib in #ROS1 fusion-positive sinonasal mucosal #melanoma #ROS1agnostic #cancer https://t.co/3ema9u6FQG

04 Jun 2024

Reply Repost Favourite

Case report: complete remission with crizotinib in ROS1 fusion-positive sinonasal mucosal melanoma: Introduction Sinonasal mucosal melanoma (SNMM) originates from melanocytes. Currently, the main treatment methods, including… #oncology https://t.co/UNHkgO

24 Oct 2022

Reply Repost Favourite

New research: Case report: complete remission with crizotinib in ROS1 fusion-positive sinonasal mucosal melanoma: Introduction Sinonasal mucosal melanoma (SNMM) originates from melanocytes. Currently, the main treatment methods, including… https://t.co/vd

20 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.